Patent ID: 9457042
Filing Date: 2016-10-04
CPC Classification: A61K,A61P,C12N,C12Q,G01N

Claim Text:
1. A composition comprising a combination of: at least one type of a CIP2A silencing agent selected from the group consisting of an siRNA molecule having at least 80% sequence identity to a sequence selected from SEQ ID NOS: 1-5 and having CIP2A silencing activity, and an shRNA molecule having at least 80% sequence identity to a sequence selected from SEQ ID NOS: 10-13 and 19 and having CIP2A silencing activity; at least one compound selected from the group consisting of PKC-412, PARP inhibitor III, indol-3-carbinol, cisplatin, rapamycin, TGX-221, NU-7441, S31-201, and gemcitabine; and at least one pharmaceutically acceptable carrier.